Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-03-12

Clinical Trial Update: eArly levoDopa With Opicapone in Parkinson's paTients wIth motOr fluctuatioNs. [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating early levodopa with opicapone in Parkinson's disease patients with motor fluctuations has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • OpiCapone
  • levodopa (levodopa)

Snippet

Sponsor: Bial - Portela C S.A. | Conditions: Parkinson Disease | Phase 4 | Status: COMPLETED